Literature DB >> 15585913

Isolation and generation of clinical-grade dendritic cells using the CliniMACS system.

John D M Campbell1, Christoph Piechaczek, Gregor Winkels, Edith Schwamborn, Daniela Micheli, Sonja Hennemann, Jürgen Schmitz.   

Abstract

Dendritic cells (DC) can either be generated from progenitors such as stem cells or CD14+ monocytes, or isolated directly from the blood. Blood-derived DC are present as at least two distinct populations-myeloid and plasmacytoid DC. Here we describe methods for the clinical-grade isolation of blood DC and DC precursors using the CliniMACS. We describe the isolation of ultra-pure monocytes in order to generate large numbers of monocyte-derived DC, and also new methods for the direct isolation of blood DC. Isolation of blood DC in large numbers means that natural DC with different properties can be investigated for their clinical function for the first time.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15585913     DOI: 10.1385/1-59259-862-5:055

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  7 in total

Review 1.  Immunotherapy of malignant brain tumors.

Authors:  Duane A Mitchell; Peter E Fecci; John H Sampson
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

Review 2.  Improving vaccine efficacy against malignant glioma.

Authors:  Erik Ladomersky; Matthew Genet; Lijie Zhai; Galina Gritsina; Kristen L Lauing; Rishi R Lulla; Jason Fangusaro; Alicia Lenzen; Priya Kumthekar; Jeffrey J Raizer; David C Binder; C David James; Derek A Wainwright
Journal:  Oncoimmunology       Date:  2016-06-10       Impact factor: 8.110

3.  Chemokines as novel and versatile reagents for flow cytometry and cell sorting.

Authors:  Michelle L Le Brocq; Alasdair R Fraser; Graham Cotton; Kerry Woznica; Clare V McCulloch; Kay D Hewitt; Clive S McKimmie; Robert J B Nibbs; John D M Campbell; Gerard J Graham
Journal:  J Immunol       Date:  2014-05-21       Impact factor: 5.422

4.  Antitumor Efficacy of Human Monocyte-Derived Dendritic Cells: Comparing Effects of two Monocyte Isolation Methods.

Authors:  Graça S Marques; Zélia Silva; Paula A Videira
Journal:  Biol Proced Online       Date:  2018-02-02       Impact factor: 3.244

Review 5.  Manufacturing Dendritic Cells for Immunotherapy: Monocyte Enrichment.

Authors:  Emily L Hopewell; Cheryl Cox
Journal:  Mol Ther Methods Clin Dev       Date:  2020-01-15       Impact factor: 6.698

6.  Counter-flow elutriation of clinical peripheral blood mononuclear cell concentrates for the production of dendritic and T cell therapies.

Authors:  David F Stroncek; Vicki Fellowes; Chauha Pham; Hanh Khuu; Daniel H Fowler; Lauren V Wood; Marianna Sabatino
Journal:  J Transl Med       Date:  2014-09-17       Impact factor: 5.531

7.  Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis.

Authors:  Alasdair R Fraser; Chloe Pass; Paul Burgoyne; Anne Atkinson; Laura Bailey; Audrey Laurie; Neil W A McGowan; Akib Hamid; Joanna K Moore; Benjamin J Dwyer; Marc L Turner; Stuart J Forbes; John D M Campbell
Journal:  Cytotherapy       Date:  2017-06-30       Impact factor: 5.414

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.